Comprehensive Urology

Royal Oak, Michigan 48703

3 studies enrolling now · 17 studies all time

What they study most

Benign Prostatic Hyperplasia, Bladder Cancer, Cancer of Prostate, Cellular Diagnosis, Prostate Cancer, Fecal Incontinence, Hematuria, High-Risk Non-Muscle-Invasive Bladder Cancer, Interstitial Cystitis, Non-Muscle Invasive Bladder Neoplasms, Non-muscle Invasive Bladder Cancer, Prostate Cancer, Prostate Cancer (Adenocarcinoma)

Studies at this site

• A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer — Recruiting now
• A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer — Recruiting now
• Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer — Recruiting now
• Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now
• Active Surveillance SNEP Assay Registry Trial for Prostate Cancer — Recruiting now
• A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) — Running, not enrolling
• Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate — Completed
• A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• Comparing UroLift Experience Against Rezūm — Running, not enrolling
• Axonics SacRal NeuromodulaTIon System RegisTRY Study — Completed
• Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations — Stopped early
• Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient Setting — Completed
• Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study — Completed
• Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer — Stopped early
• Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI) — Completed
• A Registry for Hereditary Cancer Risk Assessment and Genetic Testing — Completed
• ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate Biopsy — Status unconfirmed